Status:
RECRUITING
Imaging Core Aim 2, and Udall Project 2 Aim 2
Lead Sponsor:
University of Minnesota
Conditions:
Parkinson Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
More than one million people in the United States have Parkinson's disease (PD) and the prevalence is expected to double by 2040. Over 60% of these individuals will develop debilitating postural insta...
Eligibility Criteria
Inclusion
- Age 21 and up
- Implanted with MR-compatible DBS device (Medtronic Percept/Percept RC DBS System) for treatment of Parkinson's disease
- English speaking
Exclusion
- Unable to consent for themselves
- Implanted with a DBS device that is not MR compatible
- Pregnant
- Extreme claustrophobia
- Any contraindications for MRI
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06998303
Start Date
April 1 2025
End Date
July 31 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55414